Effect of Volume of Fluid Resuscitation on Metabolic Normalization in Children Presenting in Diabetic Ketoacidosis: A Randomized Controlled Trial

Publication date: April 2016
Source:The Journal of Emergency Medicine, Volume 50, Issue 4
Author(s): Katherine Bakes, Jason S. Haukoos, Sara J. Deakyne, Emily Hopkins, Josh Easter, Kim McFann, Alison Brent, Arleta Rewers
BackgroundThe optimal rate of fluid administration in pediatric diabetic ketoacidosis (DKA) is unknown.ObjectiveOur aim was to determine whether the volume of fluid administration in children with DKA influences the rate of metabolic normalization.MethodsWe performed a randomized controlled trial conducted in a tertiary pediatric emergency department from December 2007 until June 2010. The primary outcome was time to metabolic normalization; secondary outcomes were time to bicarbonate normalization, pH normalization, overall length of hospital treatment, and adverse outcomes. Children between 0 and 18 years of age were eligible if they had type 1 diabetes mellitus and DKA. Patients were randomized to receive intravenous (IV) fluid at low volume (10 mL/kg bolus + 1.25 × maintenance rate) or high volume (20 mL/kg bolus + 1.5 × maintenance rate) (n = 25 in each).ResultsAfter adjusting for initial differences in bicarbonate levels, time to metabolic normalization was significantly faster in the higher-volume infusion group compared to the low-volume infusion group (hazard ratio [HR] = 2.0; 95% confidence interval [CI] 1.0–3.9; p = 0.04). Higher-volume IV fluid infusion appeared to hasten, to a greater extent, normalization of pH (HR = 2.5; 95% CI 1.2–5.0; p = 0.01) than normalization of serum bicarbonate (HR = 1.2; 95% CI 0.6–2.3; p = 0.6). The length of hospital treatment HR (0.8; 95% CI 0.4–1.5; p = 0.5) and time to discharge HR (0.8; 95% CI 0.4–1.5; p = 0.5) did not differ between treatment groups.ConclusionsHigher-volume fluid infusion in the treatment of pediatric DKA patients significantly shortened metabolic normalization time, but did not change overall length of hospital treatment. ClinicalTrials.gov ID NCT01701557.



from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1pA6tCC